LUNG CANCER METASTATIC
Clinical trials for LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise for tough lung cancer
Disease control CompletedThis study tested a new drug combination (bemcentinib plus pembrolizumab) in 99 people with advanced lung adenocarcinoma that had already been treated. The goal was to see if the combo could shrink tumors or slow the cancer. Participants were grouped based on their prior treatmen…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: BerGenBio ASA • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Blood markers may predict immunotherapy success in advanced cancers
Knowledge-focused CompletedThis study aimed to find blood-based markers that could predict how well cancer immunotherapy works. Researchers collected blood samples from 135 adults with advanced lung cancer, lymphoma, or urologic cancers before and during treatment. They measured immune-suppressing cells an…
Matched conditions: LUNG CANCER METASTATIC
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated May 06, 2026 16:13 UTC